BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 18, 2016
View Archived Issues
Adjuvanted rabies vaccine from Yisheng Biopharma given U.S. orphan drug status for HCC
Read More
Advaxis initiates phase III trial of ADXS-11-001 in high-risk locally advanced cervical cancer
Read More
Celgene initiates first-in-human study of CC-90009 in relapsed or refractory AML
Read More
Imago initiates phase I trial of IMG-7289 in patients with advanced myeloid malignancies
Read More
Apitope regains global rights to ATX-MS-1467 from Merck KGaA
Read More
Omeros reports phase II data for OMS-721, pursuing FDA breakthrough therapy designation
Read More
Pfizer to begin shipping Inflectra next month
Read More
89Zr-Girentuximab imaging evaluated in first-in-human renal cell carcinoma study
Read More
Addex Therapeutics to initiate phase IIa trial of dipraglurant in focal cervical dystonia
Read More
European Commission approves Onivyde
Read More
Envisia Therapeutics releases interim data from ENV-515 phase II trial
Read More
EMA gives orphan drug designation to Eiger's exendin 9-39
Read More
FDA accepts NDA resubmission for sodium zirconium cyclosilicate
Read More
Positive opinion handed down in E.U. for SomaKit TOC
Read More
Responses seen with cabozantinib plus nivolumab in patients with genitourinary tumors
Read More
Sichuan Haisco Pharmaceutical patents M3 receptor antagonists and/or beta2-adrenoceptor agonists
Read More
Mutabilis discloses beta-lactamase inhibitors
Read More
Takeda Pharmaceutical describes MGL inhibitors
Read More
Jubilant Biosys develops HUNK1 inhibitors
Read More
Toray Industries presents kappa-opioid agonists
Read More
Regeneron and Teva update status of fasinumab programs
Read More
MYH7 mutations may be involved in nemaline myopathies with cardiomyopathy
Read More
PTC Therapeutics offers U.S. and E.U. regulatory update on Translarna
Read More
RYR3 variants may cause nemaline myopathy and fiber type disproportion
Read More
Zynerba offers updates on lead programs ZYN-001 and ZYN-002
Read More
Brain imaging successful with [11C]CB-184 in healthy human subjects
Read More